Table 2.
Correlation studiesc
| Allele/haplotype | Anti-GAD |
Anti-IA2 |
||
|---|---|---|---|---|
| r2a | P | r2 | P | |
| Allelesb | ||||
| DRB1*030101 | 0.378 | 6.5 × 10−5 | 0.074 | 0.563 |
| DRB1*040101 | 0.122 | 0.211 | 0.219 | 0.084 |
| DRB1*070101 | −0.322 | 0.001 | −0.185 | 0.148 |
| DRB1*110101 | −0.345 | 3.2 × 10−4 | −0.329 | 0.009 |
| DQB1*030101 | −0.294 | 0.002 | −0.220 | 0.083 |
| DRB1*060101 | −0.129 | 0.189 | −0.009 | 0.945 |
| Haplotypes | ||||
| DRB1*030101/ DQB1*0201 | 0.572 | 1.5 × 10−10 | 0.104 | 0.419 |
| DRB1*040101/ DQB1*0302 | 0.284 | 0.003 | 0.312 | 0.013 |
| DRB1*070101/ DQB1*0201 | −0.328 | 0.001 | −0.176 | 0.168 |
| DRB1*110101/ DQB1*030101 | −0.346 | 2.8 × 10−4 | −0.343 | 0.006 |
Spearman correlation coefficient.
Only alleles and haplotypes significantly associated with altered risk of T1DM in Tunisians (7).
Boldface indicates statistical significance.